Nyse bdx.

April 16, 2021 By Sean Whooley. The FDA has identified another recall for the Alaris infusion pump from BD (NYSE:BDX) as Class I, the most serious kind of recall. BD’s latest recall, initiated on March 3, 2021, involves its BD Alaris infusion pump module system, which includes an infusion pump and vital signs monitoring system with a PC unit ...Becton Dickinson and Company stock price (BDX) NYSE: BDX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. …FRANKLIN LAKES, N.J., April 25, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable ...FRANKLIN LAKES, N.J., Jan. 5, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its first quarter of fiscal year 2022 on ...FRANKLIN LAKES, N.J., Feb. 23, 2022 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that embecta, the diabetes care business that is expected to spin off from BD on April 1, 2022, will host a virtual Investor Event on March 7, 2022. The event will begin at …

Nov 24, 2023 · Complete Becton Dickinson & Co. stock information by Barron's. View real-time BDX stock price and news, along with industry-best analysis. On Friday, Becton Dickinson and Co (BDX:NYQ) closed at 238.89, 4.49% above its 52-week low of 228.62, set on Mar 13, 2023. Data delayed at least 15 minutes, as of Nov 24 2023 18:10 GMT. Latest Becton Dickinson and Co (BDX:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Friday, the FDA said that Becton, Dickinson, And Company BDX is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health Inc's CAH Monoject syringes. The FDA has ...Nov 30, 2023 · About BDX. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Becton, Dickinson and Company (NYSE:BDX) is a favorite amongst institutional investors who own 90% [email protected] (Simply Wall St) …GAAP and adjusted diluted EPS from continuing operations were $0.53 and $3.42, respectively. For the full fiscal year 2023, BDX's revenue reached $19.4 billion, marking a 2.7% increase as reported ...BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and ...DUBLIN, IRELAND , June 20, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase the ...

2023 ж. 08 қар. ... Becton, Dickinson and Company(NYSE:BDX): Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ...

Becton Dickinson and Co (NYSE:BDX) 235.80 Delayed Data As of Nov 29 +0.11 / +0.05% Today’s Change 228.62 Today ||| 52-Week Range 287.32 -7.27% Year-to-Date Quote Profile News Charts Forecasts...

The latest price target for . Becton Dickinson (NYSE: BDX) was reported by Piper Sandler on Friday, November 10, 2023.The analyst firm set a price target for 280.00 expecting BDX to rise to within ...FRANKLIN LAKES, N.J., Nov. 30, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today issued the following statement regarding ...DUBLIN (2 June 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today held a grand opening ceremony for a new €4 million research and development facility in Blackrock, Dublin and announced an additional €30 million investment to expand its manufacturing facility in Enniscorthy, Wexford. The …Medical technology company Becton, Dickinson & Co (NYSE: BDX) saw shares plummet recently on weaker-than-expected guidance. The company expects revenues of between $20.1 billion and $20.3 billion ...FRANKLIN LAKES, N.J., Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will present the next ...

2022 ж. 26 қаң. ... Becton, Dickinson and Company (NYSE: BDX) Rings The Closing Bell®. New York Stock Exchange•1K views · 4:16 · Go to channel ...BD Announces Completion of Embecta Corp. Spinoff. FRANKLIN LAKES, N.J. (April 1, 2022) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed its spinoff of Embecta Corp. (embecta) (NASDAQ: EMBC), which holds BD's former Diabetes Care business …MSFT. 377.43. -0.11%. 9.38M. View today's Becton Dickinson and Company stock price and latest BDX news and analysis. Create real-time notifications to follow any changes in the live stock price.One of the largest of these companies is Becton, Dickinson and Co. ( NYSE: BDX) which develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products ...With its stock down 6.3% over the past month, it is easy to disregard Becton Dickinson (NYSE:BDX). However, the company's fundamentals look pretty decent, and long-term financials are usually ...Becton, Dickinson and Company (NYSE:BDX) Insider Buying and Selling Activity. Current Insider Ownership Percentage 0.31%. Number Of Insiders Buying (Last 12 Months) 0. Number Of Insiders Selling (Last 12 Months) 4. Amount Of Insider Selling (Last 12 Months) $2.42 M. Get BDX Insider Trade Alerts.

Polar Capital Holdings Plc bought a new stake in Becton, Dickinson and Company (NYSE:BDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 134,996 shares of the medical instruments supplier's stock, valued at appr

Becton, Dickinson and Company Price Performance. Shares of BDX stock traded up $0.46 during trading hours on Wednesday, hitting $236.62. The stock had a trading volume of 762,195 shares, compared ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety...BDX is a leader in this field. Reply. Recs. Dividends500 85.52 ) Submitted: 12/31/2020 12:45:18 AM : $239.30 NYSE:BDX Score: -22.87. Dividends500 tracks the healthiest dividends in the S&P 500. To qualify for the portfolio, the company must meet three simple requirements: - Member of the S&P 500 - Payout ratio below 50% - Dividend growth year ...Becton, Dickinson and Company Common Stock (BDX) Stock Price, Quote, News & History | Nasdaq MY QUOTES: BDX Edit my quotes Becton, Dickinson and Company Common …WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 …Nov 2, 2023 · The top 21 shareholders own 51% of the company. Insiders have been selling lately. A look at the shareholders of Becton, Dickinson and Company ( NYSE:BDX) can tell us which group is most powerful ... HCA vs. BDX, HUM, GSK, MCK, BSX, ZTS, CI, REGN, TAK, and DXCM. Should you be buying HCA Healthcare stock or one of its competitors? The main competitors of HCA Healthcare include Becton, Dickinson and Company (BDX), Humana (HUM), GSK (GSK), McKesson (MCK), Boston Scientific (BSX), Zoetis (ZTS), The Cigna Group (CI), …2023 ж. 24 шіл. ... The healthcare stock is up more than 10% so far this year. Expand. NYSE: BDX. Becton, Dickinson And.

Becton, Dickinson (NYSE:BDX) has never been my favorite name among med-techs, but there is something to be said for a company with commanding share in many essential med-surg markets and where ...

Becton, Dickinson ( NYSE: BDX) will sell its surgical instrumentation platform to STERIS ( NYSE: STE) for $540M. BD ( BDX) said the move supports its strategy of simplifying its product portfolio ...

Jul 13, 2023 · Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ... Becton, Dickinson: (BDX) - A Quality Defensive Pick BDX gapping higher and may be breaking out of this 5-year range it's been trading in. This serial-acquirer is a buy. This serial-acquirer is a buy. Over the longer-term, Becton Dickinson has been a solid compounder, and the current valuation represents a reasonable entry point. FRANKLIN LAKES, N.J., Nov. 10, 2022 / PRNewswire / -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, an increase of 4.6% from the previous quarter. The dividend will be payable on Dec. 30, 2022 to holders of record on Dec. 9, 2022.FRANKLIN LAKES, N.J., Jan. 5, 2023 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2023 on Thursday, February 2, 2023.Dec 1, 2023 · Earnings for Becton, Dickinson and Company are expected to grow by 10.68% in the coming year, from $12.83 to $14.20 per share. Becton, Dickinson and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 1st, 2024 based off prior year's report dates. Read More. 12. Becton, Dickinson and Company (NYSE:BDX) Dividend Yield as of February 14: 1.50%. Number of Hedge Fund Holders: 52 Becton, Dickinson and Company (NYSE:BDX), also known simply as BD, is an ...In the fiscal second quarter of 2021, Becton, Dickinson and Company (NYSE: BDX) had an EPS of $3.19, beating estimates by $0.15. The company’s revenue was $4.91 billion, up 15.38% year over year ...Becton, Dickinson: (BDX) - A Quality Defensive Pick BDX gapping higher and may be breaking out of this 5-year range it's been trading in. This serial-acquirer is a buy. This serial-acquirer is a buy. Over the longer-term, Becton Dickinson has been a solid compounder, and the current valuation represents a reasonable entry point.Becton, Dickinson and Company has increased its dividend for the past 51 consecutive years. When did Becton, Dickinson and Company last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.04 on Thursday, November 9, 2023.

Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that specializes in the development, manufacturing, and distribution of a wide range of medical devices, laboratory ...Nov 29, 2023 · The average twelve-month price prediction for Becton, Dickinson and Company is $283.86 with a high price target of $310.00 and a low price target of $260.00. Learn more on BDX's analyst rating history. Do Wall Street analysts like Becton, Dickinson and Company more than its competitors? BDX Put and Call Options List 1/17/2025 6/21/2024 3/15/2024 2/16/2024 1/19/2024 12/15/2023 Options Date Put and Call Options Put Options Call Options Options TypeInstagram:https://instagram. best commodity brokerseasiest day trading platformcummins stocksindpendent financial About BDX. Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. one dollar liberty coinhow do you buy stock directly from a company Becton, Dickinson and Company (NYSE:BDX) Q4 2023 Earnings Call Transcript. Published on November 10, 2023 at 1:39 pm by Insider Monkey Transcripts in News, Transcripts. Share Tweet ... pm simulated trading FRANKLIN LAKES, N.J., Jan. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it has been included in the ...Nov 24, 2023 · Complete Becton Dickinson & Co. stock information by Barron's. View real-time BDX stock price and news, along with industry-best analysis. FRANKLIN LAKES, N.J. (June 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems (PS), effective today. Boros will be responsible for driving global strategic, operational and commercial performance of the PS ...